👁️ GLP-1. Vision. Vigilance: The Hidden Ocular Signal of Dulaglutide

👁️ New NEJM correspondence highlights a potentially important ophthalmic signal linked to dulaglutide therapy. Two patients developed choroidal lymphoid hyperplasia with painless visual loss within months of GLP-1 receptor agonist initiation. Remarkably, ocular and systemic findings rapidly resolved after stopping dulaglutide. As GLP-1 therapies expand across diabetes, obesity, and cardiometabolic medicine, clinicians should remain vigilant for emerging ocular adverse events. A fascinating intersection of endocrinology, immunology, and ophthalmology. 🔬💉👓 #NEJM #GLP1 #Dulaglutide #Ophthalmology #Diabetes #Retina #Cardiology #ObesityMedicine #PrecisionMedicine #MedicalEducation